Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients
(Q51558091)
scientific article
scientific article
Language:
Current Data About
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients
other details
description | scientific article |
External Links
(P356) |
10.1046/J.1464-5491.2000.00224.X
|
(P698) |
10691158
|